Equities

Blue Jet Healthcare Ltd

BLUEJET:NSI

Blue Jet Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)528.20
  • Today's Change-5.80 / -1.09%
  • Shares traded224.44k
  • 1 Year change+41.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 10:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in INR

The 3 analysts offering 12 month price targets for Blue Jet Healthcare Ltd have a median target of 550.00, with a high estimate of 600.00 and a low estimate of 425.00. The median estimate represents a 4.45% increase from the last price of 526.55.
High13.9%600.00
Med4.5%550.00
Low-19.3%425.00

Dividends

In 2024, Blue Jet Healthcare Ltd reported a dividend of 1.00 INR. The 2 analysts covering the company expect dividends of 1.35 INR for the upcoming fiscal year, an increase of 35.00%.
Div growth (TTM)--
More ▼

Earnings history & estimates in INR

On Oct 29, 2024, Blue Jet Healthcare Ltd reported 2nd quarter 2025 earnings of 3.36 per share.
The next earnings announcement is expected on Jun 02, 2025.
Average growth rate+24.66%
Blue Jet Healthcare Ltd reported annual 2024 earnings of 10.00 per share on May 25, 2024.
More ▼

Revenue history & estimates in INR

Blue Jet Healthcare Ltd had 2nd quarter 2025 revenues of 2.08bn. This missed the 2.24bn estimate of the one analyst following the company. This was 13.22% above the prior year's 2nd quarter results.
Average growth rate+8.20%
Blue Jet Healthcare Ltd had revenues for the full year 2024 of 7.12bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.